Nextonic Solutions is redefining cancer research through 3D bioprinting. Led by our CEO Kristy Derr, first author on a pioneering study in Tissue Engineering Part C, we’ve developed human-relevant skin tissue models that mimic real epidermal and dermal structure. These bioprinted constructs are accelerating therapeutic discovery for melanoma and squamous cell carcinoma by offering scalable, accurate, and ethically responsible alternatives to traditional models.